retatrutide 2025 vs tirzepatide for weight loss Retatrutide: The triple-action peptide revolutionizing

However, it remains an investigational medicine , and more evidence is needed before it can be approved and prescribed in the UK

Checking the medication for clarity and expiration

H., Mitchell, C

These GLP-1s can also safely be used off label for weight loss

Cardiovascular benefits as weight loss and improved metabolic markers could lower heart disease risk

Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement